BELGRADE (Serbia), March 22 (SeeNews) – Serbian state-owned drug maker Galenika posted a combined loss of 14 million euro ($19.9 million) last year as a result of the depreciation of the local currency, the dinar, uncollected receivables and big interest payments, local media reported.
about 2 hours agoabout 3 hours agoabout 3 hours agoabout 4 hours ago
about 2 hours agoabout 3 hours agoabout 3 hours agoabout 4 hours agoJun 10, 2026
BucharestJun 30, 2026Marrakech
